Immunohistochemistry performed on prostate cancer tissue and lymph node metastases sections showed similar distribution of PRK1 and SPAG9 (Figure 6C), indicating their relevance in prostate cancer progression. This evidence concerns the gene PKN1 and prostate carcinoma.